| Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study. | |
| | |
MedLine Citation:
|
PMID: 20648558 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The aim of this study was to investigate the effect of inhibiting α(v) β(3) /α(v) β(5) integrins by cilengitide in experimentally induced breast cancer bone metastases using noninvasive imaging techniques. For this purpose, nude rats bearing established breast cancer bone metastases were treated with cilengitide, a small molecule inhibitor of α(v) β(3) and α(v) β(5) integrins (75 mg/kg, five days per week; n = 12 rats) and compared to vehicle-treated control rats (n = 12). In a longitudinal study, conventional magnetic resonance imaging (MRI) and flat panel volumetric computed tomography were used to assess the volume of the soft tissue tumor and osteolysis, respectively, and dynamic contrast-enhanced (DCE-) MRI was performed to determine functional parameters of the tumor vasculature reflecting blood volume and blood vessel permeability. In rats treated with cilengitide, VCT and MRI showed that osteolytic lesions and the respective bone metastatic soft tissue tumors progressed more slowly than in vehicle-treated controls. DCE-MRI indicated a decrease in blood volume and an increase in vessel permeability and immunohistology revealed increased numbers of immature vessels in cilengitide-treated rats compared to vehicle controls. In conclusion, treatment of experimental breast cancer bone metastases with cilengitide resulted in pronounced antiresorptive and antitumor effects, suggesting that α(v) β(3) /α(v) β(5) inhibition may be a promising therapeutic approach for bone metastases. |
| | |
Authors:
|
Tobias Bäuerle; Dorde Komljenovic; Maximilian Merz; Martin R Berger; Simon L Goodman; Wolfhard Semmler |
Related Documents
:
|
12605178 - Interstitial ct lymphography-guided localization of breast sentinel lymph node: prelimi... 18491098 - Segmental enhancement on breast mr images: differential diagnosis and diagnostic strategy. 8460218 - Fat-suppressed three-dimensional mr imaging of the breast. 20808988 - The efficacy of (99m)tc-mibi scintimammography in the evaluation of breast lesions and ... 9510428 - Changes in magnetic resonance imaging and sex behavior after 6-ohda injection in the me... 16484418 - The study of cerebral hemodynamics in the hyperacute stage of fat embolism induced by t... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: International journal of cancer. Journal international du cancer Volume: 128 ISSN: 1097-0215 ISO Abbreviation: Int. J. Cancer Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-03-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0042124 Medline TA: Int J Cancer Country: United States |
Other Details:
|
Languages: eng Pagination: 2453-62 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 UICC. |
Affiliation:
|
Department of Medical Physics in Radiology, German Cancer Research Center, Heidelberg, Germany. t.baeuerle@dkfz.de. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutation.
Next Document: Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitr...